Sofinnova Partners

Sofinnova Partners stands as a premier European venture capital organization dedicated to life sciences investments, with a dual focus on healthcare innovation and sustainability solutions. Established in 1972, this deeply-rooted financial institution has cultivated five decades of expertise in nurturing scientific breakthroughs across Europe and beyond. With operational hubs in Paris, London, and Milan, the firm leverages its pan-European presence to identify promising opportunities throughout the continent's innovation ecosystem.

The investment team comprises a diverse collective of international professionals who bring together exceptional scientific knowledge, medical expertise, and business acumen. This multidisciplinary approach enables Sofinnova to evaluate complex scientific propositions with precision while simultaneously assessing market potential and commercial viability. As a hands-on company builder, the firm doesn't merely provide capital but actively participates in strategic development, offering guidance through the intricate challenges of bringing life science innovations from laboratory to market.

Sofinnova's investment philosophy encompasses the entire spectrum of life sciences funding, from early seed investments in nascent technologies to later-stage capital for maturing enterprises. This comprehensive approach allows them to support promising ventures throughout their entire development journey, often serving as lead or cornerstone investor in transformative companies. Their portfolio reflects a commitment to backing ambitious entrepreneurs whose innovations address significant unmet needs and possess the potential to create meaningful societal impact in healthcare delivery, disease management, and environmental sustainability.

With an impressive track record spanning over 500 company investments and numerous market leaders created across global markets, Sofinnova has demonstrated remarkable longevity and success in the volatile life sciences sector. The firm currently manages an investment portfolio exceeding €4 billion, positioning it among Europe's most substantial dedicated life sciences investors. This financial capacity, combined with 50 years of specialized investment experience, enables Sofinnova to continue its mission of transforming scientific potential into commercial reality while generating returns for investors and advancing solutions for pressing healthcare and sustainability challenges.